HomeSYRS • NASDAQ
Follow
Syros Pharmaceuticals Inc
Previous close
$5.84
Day range
$5.15 - $5.90
Year range
$2.09 - $8.17
Market cap
137.28M USD
Avg Volume
188.52K
P/E ratio
3.52
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 3.76M | -3.32% |
Operating expense | 7.76M | -3.86% |
Net income | -40.14M | -32.69% |
Net profit margin | -1.07K | -37.24% |
Earnings per share | -1.35 | 57.94% |
EBITDA | -31.67M | -7.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 112.22M | -54.10% |
Total assets | 147.80M | -48.09% |
Total liabilities | 111.49M | -28.33% |
Total equity | 36.30M | — |
Shares outstanding | 21.07M | — |
Price to book | 3.34 | — |
Return on assets | -49.09% | — |
Return on capital | -68.74% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -40.14M | -32.69% |
Cash from operations | -31.86M | 10.98% |
Cash from investing | 28.64M | 362.53% |
Cash from financing | -5.00K | -100.00% |
Net change in cash | -3.22M | -102.87% |
Free cash flow | -20.35M | -189.71% |
About
Founded
2011
Website
Employees
68